Table 2.

Demographic and clinical characteristics stratified by PAMORA offered

	Offered (n = 58)	Not offered (n = 146)	P
Age in years (mean ± std)	57.9 ± 14.7	56.7 ± 17.0	0.63
BMI (mean ± std)	27.8 ± 7.1	27.2 ± 7.0	0.64
ECI (mean ± std)	7.7 ± 5.5	7.6 ± 4.7	0.89
Sex (male:female)	21:37	67:79	0.24
Race (Caucasian:other)	50:08	117:29	0.31
Insurance (private:other)	22:36	55:91	0.96
MME (mean ± std)	121.42 ± 199.20	108.10 ± 120.57	0.56
Laxatives trialed (mean ± std)	2.84 ± 1.32	2.87 ± 0.99	0.89
Department			<0.001
Palliative, n (%)	6 (18)	27 (82)
Primary care, n (%)	6 (16)	32 (84)
Gastroenterology, n (%)	40 (59)	28 (41)
Oncology, n (%)	4 (8)	46 (92)
Other, n (%)	2 (13)	13 (87)

P values less than 0.05 are given in bold. “Primary Care” department includes internal medicine and family medicine primary care. “Other” department includes PMR, surgery, OBGYN, neurology, psychiatry, and medicine subspecialties including pulmonology, nephrology, rheumatology, geriatrics, and endocrine.

BMI, body mass index; ECI, Elixhauser comorbidity index; MME, morphine milligram equivalent; PAMORA, peripherally acting u-opioid receptor antagonists.